CREB1 and non-small cell lung carcinoma: Taken altogether, our study demonstrated that cisplatin-induced CREB expression contributes to the differential cellular response to cisplatin in NSCLC, and CREB inhibition effectively sensitize NSCLC tumor spheroids and tumors to cisplatin.